Bio Port Korea Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	72,620	73,346	68,699
Revenue Growth (YoY)	-0.26%	6.77%	-
Cost of Revenue	52,628	52,411	49,616
Gross Profit	19,992	20,936	19,083
Selling, General & Admin	15,240	14,507	13,179
Research & Development	604.83	504.95	457.61
Amortization of Goodwill & Intangibles	19.53	9.48	9.48
Other Operating Expenses	220.76	163.69	133.25
Operating Expenses	16,760	15,696	14,164
Operating Income	3,232	5,240	4,919
Interest Expense	-754.7	-1,512	-2,108
Interest & Investment Income	492.56	517.44	408.99
Currency Exchange Gain (Loss)	-116.04	544.78	206.96
Other Non Operating Income (Expenses)	-2,235	1,467	182.24
EBT Excluding Unusual Items	618.84	6,258	3,609
Gain (Loss) on Sale of Investments	-	18.23	-13.91
Gain (Loss) on Sale of Assets	-6.7	-924.59	-
Pretax Income	612.14	5,352	3,595
Income Tax Expense	-32.09	1,240	225.62
Net Income	644.23	4,112	3,369
Net Income to Common	644.23	4,112	3,369
Net Income Growth	-79.92%	22.04%	-
Shares Outstanding (Basic)	4	3	3
Shares Outstanding (Diluted)	4	4	4
Shares Change (YoY)	28.24%	1.04%	-
EPS (Basic)	184.04	1465.53	1347.75
EPS (Diluted)	184.04	1438.99	1302.58
EPS Growth	-85.66%	10.47%	-
Free Cash Flow	6,764	8,491	-1,253
Free Cash Flow Per Share	1582.92	2372.83	-353.75
Gross Margin	27.53%	28.54%	27.78%
Operating Margin	4.45%	7.14%	7.16%
Profit Margin	0.89%	5.61%	4.91%
Free Cash Flow Margin	9.31%	11.58%	-1.82%
EBITDA	5,377	7,102	6,328
EBITDA Margin	7.40%	9.68%	9.21%
D&A For EBITDA	2,145	1,862	1,409
EBIT	3,232	5,240	4,919
EBIT Margin	4.45%	7.14%	7.16%
Effective Tax Rate	-	23.16%	6.28%
Advertising Expenses	-	966.01	768.83

Source: S&P Global Market Intelligence. Standard template. Financial Sources.